AMPLIPHI BIOSCIENCES CORP SC13G

Company

Armata Pharmaceuticals, Inc.

Filed

January 30, 2017

Accession Number

0001393825-17-000006

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →